Immunome Inc (IMNM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Immunome Inc-Aktie (IMNM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	4.015	2.926	2.738
Operating Expenses	21.16% 72.86	60.14	50.49	47.56	85.71
Benefits Costs and Expenses	21.66% 69.90	57.46	-	44.57	82.99
Costs And Expenses	21.66% 69.90	57.46	50.49	44.57	82.99
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	21.16% -72.86	-60.14	-46.48	-44.64	-82.97
Net Interest Income/Expense	10.44% 2.961	2.681	3.081	2.996	2.721
Interest Income/Expense After Provision For Losses	10.44% 2.961	2.681	3.081	2.996	2.721
Income/Loss From Continuing Operations Before Tax	21.66% -69.90	-57.46	-43.40	-41.64	-80.25
Income/Loss From Continuing Operations After Tax	21.66% -69.90	-57.46	-43.40	-41.64	-80.25
Net Income/Loss	21.66% -69.90	-57.46	-43.40	-41.64	-80.25
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	97.13% 2.5267	87.96	87.01	79.41	1.3998
Diluted Average Shares	97.13% 2.5267	87.96	87.01	79.41	1.3998
Basic Earnings Per Share	15.38% -0.75	-0.65	-0.50	-0.52	-1.28
Diluted Earnings Per Share	15.38% -0.75	-0.65	-0.50	-0.52	-1.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%